The opposite of “more”

Focus of generic pharmaceutical company is mainly on navigating the innovator’s intellectual property and not necessarily on developing a patentable product. Products are developed irrespective of whether they are patentable or not. Once developed (or development strategy is finalized), it is reviewed, and a patent application is filed.  Here the value of patent/application primarily lies […]